Senseonics Announces Innovative CGM System Virtual Event
Innovative Virtual Event on Eversense 365 by Senseonics
Senseonics Holdings, Inc. (NYSE American: SENS), a pioneering medical technology company, has recently announced an innovative virtual event focused on the Eversense 365 Continuous Glucose Monitoring (CGM) system. This highly anticipated event is set to take place on a future date, and it invites healthcare professionals and diabetes management enthusiasts to learn about the groundbreaking advancements in CGM technology.
Highlights of Eversense 365
The Eversense 365 system represents a remarkable leap in diabetes management technology, earning recent clearance from the U.S. Food and Drug Administration. This makes it the world's first CGM system capable of providing continuous glucose measurements for an entire year. This extended monitoring capability differentiates it significantly from conventional options, providing patients with greater reliability and convenience in managing their diabetes.
Expert Insights at the Event
This virtual gathering will feature key opinion leaders in the field, including health professionals who specialize in diabetes management. Attendees will gain insights from experts on how the Eversense 365 system is being integrated into clinical practice, its benefits for Type 1 and Type 2 diabetes patients aged 18 years and older, and the overarching commercial collaboration with esteemed healthcare systems.
Live Q&A Session
Participants can also look forward to an interactive question and answer session that will follow the primary presentations, allowing for a deeper understanding of the system's capabilities and applications. This format aims to encourage dialogue between experts and attendees, fostering a collaborative atmosphere for discussion and inquiry.
The Importance of CGM Technology
Continuous Glucose Monitoring represents a significant advancement in diabetes care, ensuring that patients keep their glucose levels in check more efficiently. The Eversense 365 offers a small sensor that is implanted subcutaneously and communicates with a transmitter worn on the body, sending glucose readings automatically to a mobile application every five minutes. This technology not only simplifies monitoring but also enhances patient engagement in their health management.
About Senseonics and Eversense
Senseonics is dedicated to revolutionizing diabetes care with its Eversense systems, which deliver real-time glucose data and empower users to make informed health decisions. The commitment to patient-centric solutions drives the company to continuously innovate, ensuring that those living with diabetes have access to the best possible resources and technology.
Collaboration with Mercy Healthcare
Furthermore, the event will elaborate on Senseonics’ collaboration with Mercy, a renowned healthcare provider, and emphasize how this partnership enhances patient access to the Eversense 365 system. Their comprehensive healthcare approach has been pivotal in improving patient experiences and outcomes in diabetes management.
Frequently Asked Questions
What is the Eversense 365 system?
The Eversense 365 is a Continuous Glucose Monitoring (CGM) system that allows for continuous glucose tracking for up to one year, providing significant advantages over traditional CGMs.
How can I register for the virtual event?
Interested attendees can register for the event through Senseonics' official communication channels or updates that will be shared in the coming weeks.
Who will be speaking during the event?
The event will feature several key opinion leaders and healthcare professionals specialized in diabetes management, providing valuable insights and expertise.
Is the Eversense 365 system suitable for all diabetes patients?
This system is designed for individuals aged 18 and older with Type 1 and Type 2 diabetes; consulting a healthcare provider is vital to determine individual suitability.
Where can I learn more about Senseonics and their products?
For more information about Senseonics' offerings and the Eversense systems, patients and providers are encouraged to visit Senseonics' official website and their investor relations section.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Oriental Rise Holding Limited Announces Initial Public Offering Details
- AirBoss Announces Earnings Release and Conference Call Details
- Caracal and I2Pure Collaborate for Innovative Antimicrobial Solutions
- Innovative Lab Services Expands Reach with MLS Technologies Acquisition
- Telerehabilitation Systems Market Growth Projection to 2028
- T2 Biosystems Unveils New Product Developments and Revenue Growth
- Carriage Services Announces New Quarterly Dividend for 2024
- Parker Hannifin Announces Webcast for Annual Shareholder Meeting
- Timbercreek Financial Announces Upcoming Conference Call
- Carriage Services Announces Attractive Cash Dividend for Shareholders
Recent Articles
- DuPont Declares Quarterly Dividend to Shareholders Impacting 2024
- Lexicon Partners with Viatris for Global Sotagliflozin Sales
- NeuroPace Strengthens Leadership with New HR Vice President
- Steel Dynamics Delivers Strong Q3 2024 Performance Metrics
- Capricor Therapeutics Announces Strategic Public Offering Plans
- Unicycive Therapeutics Engages in Discussion at Healthcare Summit
- Coherent Corp. Announces Inducement Grants for New CFO
- Signing Day Sports Announces Warrant Price Reduction Strategy
- Viatris Strengthens Portfolio with Lexicon Licensing Deal
- Prudential Financial Hits $1.4 Trillion in Assets: A Closer Look
- Nurix Therapeutics Strengthens Leadership with Anil Kapur's Appointment
- Lucid Group Launches Major Stock Offering to Fuel Growth
- Discover Financial Services Exceeds Q3 Projections Amid Growth
- J & J Snack Foods Outlines Plans for Upcoming Earnings Call
- Brazilian Stock Market Sees Positive Gains; Bovespa Rises Steadily
- SL Green Realty Corp. Announces Key Q3 2024 Financial Results
- Canada's Stock Market Shows Strength Amid Positive Gains
- Union Bankshares Reports Third Quarter Earnings and Dividend Announcement
- Alcoa's Strong Profit Surge Drives Share Price Upward
- Costco's Commitment to Shareholders: Quarterly Dividend Update
- U.S. Stock Market Shows Strong Performance Amid Rising Sectors
- HCI Group Updates on Storm Impact and Financial Resilience
- Oncocyte CEO to Present at LD Micro Conference in California
- Kinder Morgan's Quarterly Performance: Factors Impacting Earnings
- Banner Corporation Reports Strong Q3 Earnings Despite Revenue Setback
- Profound Medical Welcomes Tom Tamberrino as New CCO
- Understanding Target's Unusual Options Activity and Insights
- Crown Castle Reports Strong Q3 Earnings Despite Revenue Drop
- PKS Investments Shines as Albany's Premier Workplace in 2024
- Understanding Analyst Insights on Riot Platforms' Options Activity
- Nicolet Bankshares Hits Record High: What You Need to Know
- Compass Diversified Reveals Q3 2024 Earnings Call Details
- What You Need to Know About Palantir Technologies' Options Trends
- Crinetics Pharmaceuticals Announces Strategic Executive Shift
- IAC Announces Earnings Release and Conference Call Details
- New York Mortgage Trust to Hold Q3 Conference Call Soon
- Phillips 66 Announces Closure of Los Angeles Refinery Operations
- Wolfspeed Enhances Financial Agreement with Renesas for Growth
- Certara Welcomes John Reynders to the Board of Directors
- Rexford Industrial's Impressive Q3 Performance and Future Outlook
- ACRES Commercial Realty Prepares to Announce Q3 Performance
- TPG RE Finance Trust Shares Q3 2024 Earnings Call Details
- Paycor HCM to Release Financial Results for Q1 FY 2025
- Triumph Financial's Quarterly Performance Exceeds Expectations
- Floyd Mayweather's Ambitious $402M Affordable Housing Investment
- Redwood Trust, Inc. Schedules Q3 2024 Financial Results Call
- Equifax Reports Remarkable Revenue Growth in Recent Quarter
- Transform Your Investment: HCA Healthcare's Growth Journey
- Jazz Pharmaceuticals Announces Strategic Lease Termination Plans
- Capricor Therapeutics Eyes Growth with New Stock Offering